Small Business Innovation Research (SBIR) / Small Business Technology Transfer (STTR) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). The NIH and CDC SBIR/STTR programs solicit proposals from small business concerns with R&D expertise to conduct innovative research contributing to NIH or CDC mission needs. These programs aim to stimulate technological innovation, strengthen the role of small business in meeting Federal R&D needs, encourage participation by socially and economically disadvantaged small businesses, and increase private sector commercialization of innovations.

Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs (Omnibus) is sponsored by National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA). These programs encourage domestic small businesses to engage in research and development with the potential for product commercialization in areas relevant to the missions of NIH, CDC, and FDA, including medical devices, diagnostics, therapeutics, and health tech/AI.

NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Opportunities is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). NIH SBIR/STTR grant funding opportunities offer small business entrepreneurs non-dilutive funding for early-stage biomedical and behavioral research and development. Applications are accepted three times a year.

Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs (HHS) is a federal funding program from the U.S. Department of Health and Human Services (HHS) that provides non-dilutive funding to small businesses for research and development with the potential for commercialization. Commonly called America's Seed Fund, the programs support innovation in three phases: feasibility research (Phase I), technology development (Phase II), and commercialization (Phase III). Eligible applicants are U.S. for-profit small businesses with fewer than 500 employees. Typical Phase I awards are up to $250,000 and Phase II awards up to $1.5 million, varying by agency and solicitation.